5.12.1Segment

Analytical Instruments

Manufacturers of chromatography, mass spectrometry, spectroscopy, and elemental analysis instruments for laboratory and process analytical applications.

4
Verticals

Overview

Analytical Instruments covers the laboratory instruments that identify and quantify substances — chromatography, mass spectrometry, spectroscopy, and analytical systems. At ~$19B it is consolidated around analytical-instrument majors (Thermo Fisher, Agilent, Waters, Danaher, PerkinElmer/Revvity), serving pharma, biotech, environmental, food, and materials testing.

Demand is driven by pharma/biotech R&D and QC, environmental and food-safety testing, and emerging applications (PFAS, biologics), and the segment epitomizes razor-and-blade economics — instruments pull through high-margin recurring consumables (columns, reagents) and service. It is consolidated, high-margin, and a prime serial-acquirer M&A arena.

Market snapshot

Market size
~$19B
Growth
~4.6%CAGR (2017–22, nominal)
Companies
~550 firms
Firms by employee count

57.8% of firms have fewer than 20 employees: 318 micro-businesses, below most mandates.

The investable universe232 firms with 20+ employees
20–99
12453%
100–499
4720%
500+
6126%

Growth tracks pharmaceutical and biotech R&D budgets rather than industrial activity, which makes it the least cyclical segment here and the most exposed to funding conditions in life sciences. Switching costs are unusually high: methods are validated against a specific instrument and revalidation is a regulatory exercise, so an installed platform is close to annuity revenue.

NAICS 334516. U.S. Census Bureau — 2022 Statistics of U.S. Businesses; U.S. Census Bureau — 2022 Economic Census.

Business model & economics

Revenue model

Instrument sales pulling through consumables and service

Key economics

Revenue per firm
$35,189,702
Revenue per employee
$389,063
Employees per firm
84.2
Recurring revenue
High

recurring consumables (columns, reagents) and service

EBITDA margin
Strong

razor-and-blade analytical economics

Capex intensity
Moderate

Characteristics

  • Scale-driven — payroll is only 25% of revenue; the cost base is assets, not headcount
  • Moderate strategic-buyer pool — 61 firms exceed 500 employees; a scaled asset has buyers, but not many
  • Consolidated around Thermo Fisher, Agilent, Waters, Danaher.
  • Pharma/biotech R&D and QC and food/environmental testing.
  • High-margin recurring consumables and service.

NAICS 334516. U.S. Census Bureau — 2022 Statistics of U.S. Businesses; U.S. Census Bureau — 2022 Economic Census.

Geographic concentration

AlabamaAlaskaArizonaColoradoFloridaGeorgiaIndianaKansasMaineMinnesotaNew JerseyNorth CarolinaNorth DakotaOklahomaPennsylvaniaSouth DakotaTexasWyomingConnecticutMissouriWest VirginiaIllinoisNew MexicoArkansasDelawareDistrict of ColumbiaHawaiiIowaKentuckyMarylandMichiganMississippiMontanaNew HampshireNew YorkOhioOregonTennesseeUtahVirginiaWashingtonWisconsinNebraskaSouth CarolinaIdahoNevadaVermontLouisianaRhode IslandMassachusettsCalifornia

Massachusetts carries nearly four times the national concentration of analytical instrument manufacture — the Boston life-sciences cluster, where the instrument makers sit beside the pharmaceutical and academic customers that specify them.

MassachusettsCalifornia

U.S. Census Bureau — 2022 Statistics of U.S. Businesses (firms by state), NAICS 334516. Concentration shown by location quotient.

M&A deal context

Deal activityHigh

Who’s acquiring

  • Analytical-instrument majors
  • Serial-acquirer platforms
  • PE-backed specialty consolidators

What’s driving deals

  • Consumables and service razor-and-blade economics.
  • Pharma/biotech and emerging-contaminant testing.
  • Serial-acquirer roll-up of specialty instruments.

Verticals in this segment

Find Analytical Instruments acquisition targets

Search Acquisera’s index for companies classified under Analytical Instruments (5.12.1) and build a targeted deal pipeline.

Search companies